Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3557 |  WHWK Whitehawk Therapeutics, Inc. - Common Stock | 3.47 USD | +1.76% | -8.92% | -15.98% | +15.28% | 197.82 M USD | ||
| 3558 |  ACOG Alpha Cognition Inc. - Common Stock | 9.04 USD | 0.00% | +3.91% | +1.23% | +18.48% | 196.87 M USD | ||
| 3560 |  ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 2.42 USD | 0.00% | -2.42% | -12.95% | -18.79% | 196.65 M USD | ||
| 3563 |  SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 70.34 USD | -2.24% | -3.49% | +1.35% | +75.94% | 195.98 M USD | ||
| 3573 |  BCYC Bicycle Therapeutics plc - American Depositary Shares | 3.81 USD | +2.14% | +4.38% | -4.51% | -57.53% | 192.61 M USD | ||
| 3606 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 2.51 USD | -1.57% | -4.92% | -32.89% | +36.41% | 179.90 M USD | ||
| 3611 |  DTIL Precision BioSciences, Inc. - Common Stock | 6.43 USD | +2.88% | +0.16% | -10.20% | +9.35% | 177.48 M USD | ||
| 3615 |  ANTX AN2 Therapeutics, Inc. - Common Stock | 4.68 USD | -3.51% | -17.02% | -15.83% | +274.40% | 176.61 M USD | ||
| 3617 |  CMPX Compass Therapeutics, Inc. - Common Stock | 0.98 USD | -3.92% | +4.26% | -54.42% | -75.92% | 176.49 M USD | ||
| 3623 |  ORMP Oramed Pharmaceuticals Inc. - Common Stock | 4.20 USD | -3.89% | -7.28% | -11.39% | +76.47% | 174.71 M USD | ||
| 3638 |  PYXS Pyxis Oncology, Inc. - Common Stock | 1.99 USD | -1.00% | -9.95% | -41.81% | -48.04% | 165.98 M USD | ||
| 3641 |  PRQR ProQR Therapeutics N.V. - Ordinary Shares | 1.57 USD | -3.68% | -4.85% | -19.90% | -37.45% | 165.42 M USD | ||
| 3642 |  CHRS Coherus Oncology, Inc. - Common Stock | 1.07 USD | +5.94% | -10.08% | -19.55% | -33.54% | 165.32 M USD | ||
| 3643 |  PEPG PepGen Inc. - Common Stock | 2.38 USD | -0.83% | +6.25% | -23.96% | -51.43% | 164.84 M USD | ||
| 3648 |  ALXO ALX Oncology Holdings Inc. - Common Stock | 1.18 USD | +4.42% | -10.61% | -36.22% | -39.18% | 163.17 M USD | ||
| 3652 |  CUE Cue Biopharma, Inc. - Common Stock | 22.33 USD | -0.80% | -12.77% | -26.06% | +2301.08% | 162.21 M USD | ||
| 3664 |  MDWD MediWound Ltd. - Ordinary Shares | 12.42 USD | -3.35% | -8.81% | -9.61% | -33.01% | 159.41 M USD | ||
| 3666 |  NKTX Nkarta, Inc. - Common Stock | 2.22 USD | -2.20% | -14.62% | -22.92% | -5.93% | 159.01 M USD | ||
| 3668 |  NBP NovaBridge Biosciences - American Depositary Shares | 1.37 USD | 0.00% | +2.24% | -17.96% | -69.62% | 158.07 M USD | ||
| 3673 |  TARA Protara Therapeutics, Inc. - Common Stock | 2.65 USD | +2.32% | -5.69% | -30.26% | -53.51% | 156.60 M USD |
Noticias Biotechnology Stocks
El fármaco de Pharvaris para el angioedema hereditario muestra alivio más rápido
Raymond James inicia cobertura de Kymera Therapeutics con Mejor Rendimiento
Raymond James inicia cobertura de Nektar con calificación de rendimiento de mercado
Palisade Bio inicia cobertura con Mejor Rendimiento según Raymond James
Raymond James reitera su calificación de Liquidia en medio de presentaciones legales
Tenax Therapeutics pausa temporalmente la inscripción en el ensayo LEVEL-2 de TNX-103 para modificar los criterios; solicita reunión con la FDA
Ginkgo Bioworks apoyará a los X-Labs de la NSF con acceso a su laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |